BURST CME™ Plus Resource Center:
Bridging Data and Practice: Optimizing SERD Integration in HR+/HER2- Breast Cancer

Stay current with the latest advances in oral SERDs and biomarker-guided treatment strategies in HR-positive, HER2-negative breast cancer through this centralized Resource Center. Explore expert-led presentations, case-based discussions, and conference highlights that showcase targeted approaches across the disease continuum, with a focus on metastatic disease and emerging data in early-stage settings. This resource provides streamlined access to key insights, whether you are revisiting content from a live meeting or engaging with the curriculum for the first time.

This activity is supported by an educational grant from Stemline Therapeutics Inc.